marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Cyclacel Pharmaceuticals Cash Flow 2011-2024 | CYCC
Annual Cash Flow Cyclacel Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-16.1 M | -20.8 M | -18.5 M | -7.93 M | -9.45 M | -6.7 M | -7.48 M | - | - | - | - | - | - |
Depreciation & Amortization |
31 K | 32 K | 43 K | 20 K | 20 K | 29 M | 32 M | 100 K | 200 K | 200 K | 70 K | 60 K | 241 K |
Accounts Payables |
3.54 M | 2.56 M | 2.12 M | 514 K | 890 K | 2.72 M | 1.56 M | 2.5 M | 1.94 M | 2.79 M | 2.54 M | 2.26 M | 1.76 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Cyclacel Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -483 K | - | - | -6.86 M | - | -15.7 M | -8.69 M | -6.78 M | - | -14 M | -7.78 M | -3.57 M | - | -6.78 M | -4.65 M | -2.81 M | - | -8.33 M | -6.32 M | -3.68 M | - | -4.66 M | -3.94 M | -2.14 M | - | -5.26 M | -4.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 2 K | - | - | 8 K | - | 24 K | 17 K | 9 K | - | 36 K | 26 K | 9 K | - | 16 K | 10 K | 5 K | - | 15 K | 10 K | 6 K | - | 22 K | 15 K | 7 K | - | 25 K | 17 K | 9 K | - | 109 K | 75 K | 42 K | - | 157 K | 102 K | 52 K | - | 115 K | 46 K | 23 K | - | 58 K | 36 K | 26 K | - | 45 K | 30 K | 15 K | - | 250 K | 172 K | 86 K |
Accounts Payables |
4.13 M | 4.74 M | 5.2 M | 3.54 M | 2.17 M | 2.51 M | 2.56 M | 983 K | 2.2 M | 2.85 M | 2.12 M | 1.52 M | 1.2 M | 871 K | 514 K | 514 K | 514 K | 514 K | 890 K | 890 K | 890 K | 890 K | 2.72 M | 2.72 M | 2.72 M | 2.72 M | 1.56 M | 1.56 M | 1.56 M | 1.56 M | 2.5 M | 2.5 M | 2.5 M | 2.5 M | 1.94 M | 1.94 M | 1.94 M | 1.94 M | 2.79 M | 2.79 M | 2.79 M | 2.79 M | 2.54 M | 2.54 M | 2.54 M | 2.54 M | 2.26 M | 2.26 M | 2.26 M | 2.26 M | 1.72 M | 1.72 M | 1.76 M | 1.76 M |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 66 K | 600 K | - | - | 89 K | 879 K | 10 K | - | - | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 45 K | - | 116 K | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency